Vision 2028: How China could impact the global biopharma industry
McKinsey Public & Social Sector Insights
AUGUST 15, 2022
China-originated biopharmas will likely have greater influence on the industry by 2028, but regulatory developments and the quality of partnerships will determine how the industry grows.
Let's personalize your content